Clopidogrel and Bleeding After Coronary Artery Bypass Graft Surgery
Authors:
- Robert A. BakerRBRobert A. Baker
- Pallav J. ShahPSPallav J. Shah
- Vijit K. CherianVCVijit K. Cherian
- John L. KnightJKJohn L. Knight
- 1 September 2005
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 80 (3) , 928-933
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Expert Consensus Document on the Use of Antiplatelet Agents The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of CardiologyEuropean Heart Journal, 2004
- Antiplatelet treatment in stable coronary artery diseaseHeart, 2003
- Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysisHeart, 2003
- Clopidogrel for Coronary StentingCirculation, 2003
- The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developmentsAnaesthesia, 2003
- Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placementThrombosis and Haemostasis, 2003
- Antiplatelet treatment in unstable angina: aspirin, clopidogrel, glycoprotein IIb/IIIa antagonist, or all three?Heart, 2002
- Effect of clopidogrel on bleeding after coronary artery bypass surgeryCritical Care Medicine, 2001
- Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteersBritish Journal of Clinical Pharmacology, 2001
- The platelet in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1998